Cargando…
Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery
The success of lentiviral vectors in curing fatal genetic and acquired diseases has opened a new era in human gene therapy. However, variability in the efficacy and safety of this therapeutic approach has been reported in human patients. Consequently, lentiviral-vector-based gene therapy is limited...
Autores principales: | Suwanmanee, Thipparat, Ferris, Martin T., Hu, Peirong, Gui, Tong, Montgomery, Stephanie A., Pardo-Manuel de Villena, Fernando, Kafri, Tal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415322/ https://www.ncbi.nlm.nih.gov/pubmed/28480308 http://dx.doi.org/10.1016/j.omtm.2017.03.009 |
Ejemplares similares
-
Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization.
por: Hu, Peirong, et al.
Publicado: (2018) -
Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors
por: Hu, Peirong, et al.
Publicado: (2015) -
Hematopoietic Stem cell transplantation and lentiviral vector‐based gene therapy for Krabbe's disease: Present convictions and future prospects
por: Hu, Peirong, et al.
Publicado: (2016) -
Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
por: Simmons, Aaron B., et al.
Publicado: (2018) -
Correction to: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
por: Simmons, Aaron B., et al.
Publicado: (2018)